Seeking Alpha

Regeneron (REGN +1.8%) gains on positive comments out of BMO Capital this morning, saying that...

Regeneron (REGN +1.8%) gains on positive comments out of BMO Capital this morning, saying that Roche's (RHHBY.PK +2.5%) Lucentis market share is declining, and the number of patients switching to Eylea from other treatments is accelerating. The firm maintains an Outperform rating on the stock.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)